Jason Lewis, PhD, FSNMMI, Named Vice President-Elect of the Society of Nuclear Medicine and Molecular Imaging

Los Angeles -- Jason S. Lewis, PhD, FSNMMI, has been named vice president-elect of the Society of Nuclear Medicine and Molecular Imaging (SNMMI). Lewis is the Emily Tow Chair in Oncology at Memorial Sloan Kettering Cancer Center (MSK) and deputy director of Sloan Kettering Institute in New York. SNMMI introduced its 2026-27 officers at its 2026 Annual Meeting, held May 30-June 2 in Los Angeles.

"As vice president-elect, I will work to elevate the visibility of basic science across SNMMI programs, foster deeper collaboration between basic and clinical investigators, and create new opportunities for early-career scientists to engage with and contribute to the society," said Lewis. "By strengthening these connections, we can ensure that SNMMI remains a driving force behind the discoveries and innovations that shape our future."

Among his priorities, Lewis aims to strengthen SNMMI's standing as an educational leader and a vibrant forum for scientific exchange, advance high-quality education for members at all career stages, and enhance support for the next generation of investigators. He will also broaden outreach efforts to raise awareness of the field and more fully integrate basic science researchers -- whose discoveries fuel the field's innovation pipeline -- into SNMMI programs and initiatives.

Lewis holds Bachelor of Science and Master of Science degrees in chemistry from the University of Essex in Colchester and a doctorate in biochemistry from the University of Kent in Canterbury, both in the United Kingdom. He completed postdoctoral research at Washington University School of Medicine in St. Louis, where he began his faculty career as an assistant professor, and in 2008 joined MSK, where he has since held several positions.

Jason Lewis, PhD, FSNMMI

An active SNMMI member, Lewis has served the society in many capacities, including as secretary and treasurer for the past four years. He is chair of the SNMMI Task Force on Policy and Review Alignment as well as the SNMMI Committee on Finance, and is an active member of multiple committees, such as the Committee on Radiopharmaceuticals, Committee on Awards, and Clinical Trials Network Research Committee. He has also served as an associate editor of The Journal of Nuclear Medicine since 2016.

Previously, Lewis was president of both the World Molecular Imaging Society (WMIS) and the Society of Radiopharmaceutical Sciences (SRS). Lewis is a Fellow of the SNMMI, the WMIS, the SRS, the American Association for the Advancement of Science (AAAS), the Royal Society of Chemistry (RSC), the American Institute for Medical and Biological Engineering (AIMBE) and the National Academy of Inventors. He is an elected member of the International Society for Strategic Studies in Radiology (IS3R).

Lewis's contributions to the field of nuclear medicine and molecular imaging have been recognized by many organizations. He is the recipient of SNMMI s Paul C. Aebersold Award, the Michael J. Welch Award and the Dr. Saul Hertz Lifetime Achievement Award, the ACS Glenn T. Seaborg Award for Nuclear Chemistry, and the WMIS Gold Medal for Lifetime Achievement, among numerous others. He has authored over 400 publications.

Other SNMMI officers elected for 2026-27 are Heather Jacene, MD, Boston, Massachusetts, as president and Gary Ulaner, MD, PhD, FSNMMI, FACNM, Laguna Hills, California, as president-elect. SNMMI Technologist Section officers for 2026-27 are Shannon Youngblood, EdD, MSRS, CNMT, RT(CT), Greenwell Springs, Louisiana, as president and Sara L. Johnson, CNMT, RT(N)(CT), Wimauma, Florida, as president-elect.

###

About the Society of Nuclear Medicine and Molecular Imaging

The Society of Nuclear Medicine and Molecular Imaging (SNMMI) is an international scientific and medical organization dedicated to advancing nuclear medicine, molecular imaging, and theranostics -- precision medicine that allows diagnosis and treatment to be tailored to individual patients in order to achieve the best possible outcomes. For more information, visit snmmi.org.